Graham David Mullis founded Optivue LLP. Currently, Mr. Mullis is Chief Executive Officer & Executive Director at Novacyt SAS and Chief Executive Officer & Director at Lab 21 Ltd. (a subsidiary of Novacyt SAS).

He is also on the board of Microgen Bioproducts Ltd.

In the past he held the position of President & Managing Director at Clearlab SG Pte Ltd., Principal at Optivue LLP, Principal at R.P. Scherer Ltd., Vice President-Operations of Biocompatibles Eyecare, Inc. and President-International Operations at 1-800 Contacts, Inc.

Mr. Mullis received an undergraduate degree from The University of Southampton and an MBA from the University of Warwick.